Funded Health Care Startups in Sweden
The largest disclosed round in these 37 Sweden health care entries is Raysearch Laboratories’ $50M on 2025-03-18, which sits well above the next-largest di…
The largest disclosed round in these 37 Sweden health care entries is Raysearch Laboratories’ $50M on 2025-03-18, which sits well above the next-largest disclosed amounts (e.g., Enzymatica at $13M on 2024-09-12 and Cereno Scientific AB at $8M on 2025-06-20). A stage pattern also stands out: “Series Unknown” appears in 10 rows (e.g., Cereno Scientific AB 2025-06-20 $8M; Raysearch Laboratories 2025-03-18 $50M; Adsorbi 2025-01-28 “Seed” is not), while “undisclosed” appears in 3 rows (Checkproof 2024-06-04; Qbtech 2022-09-01; Doktor.se 2022-08-01). Geographically, Stockholm-based companies dominate the list (for example, Raysearch Laboratories 2025-03-18; Corsmed 2024-12-18; Tandem Health 2024-06-19), while the “Lund” cluster appears repeatedly (Enzymatica 2024-09-12; ChemoTech 2023-07-12; Cardo Health is also Stockholm-based). Temporally, rounds span from 2020-06-01 (Doctrin) to 2025-06-20 (Cereno Scientific AB), with multiple entries landing in mid-2024 (e.g., Corsmed 2024-12-18 and earlier June 2024 deals like Tandem Health 2024-06-19 and Checkproof 2024-06-04).
Most recent rounds
37 shownRelated listings
Frequently asked
What’s the largest disclosed round shown, and how far above the rest are the next disclosed deals?
Raysearch Laboratories’ disclosed $50M on 2025-03-18 is the high end of the dataset. The next-largest disclosed amounts are much lower (Enzymatica $13M on 2024-09-12 and Cereno Scientific AB $8M on 2025-06-20), so the $50M figure clearly dwarfs the next tier.
Do “Series Unknown” and “undisclosed” labels limit how much can be compared across rounds?
Yes. “Series Unknown” appears in 10 of 37 rows (including Cereno Scientific AB 2025-06-20 $8M and Raysearch Laboratories 2025-03-18 $50M), while 3 rows are “undisclosed” by amount (Checkproof 2024-06-04; Qbtech 2022-09-01; Doktor.se 2022-08-01). That reduces confidence for stage-to-size comparisons.
Which city shows the strongest geographic concentration in this Sweden health care set?
Stockholm appears repeatedly across the most recent and older entries, including Raysearch Laboratories (2025-03-18 $50M), Corsmed (2024-12-18 $4M), Tandem Health (2024-06-19 $10M), and Doctor24 (2021-05-20 $48M). In contrast, other cities show fewer repeated presences, such as Gothenburg (Adsorbi 2025-01-28 $1M; MucoLife Therapeutics 2024-09-06 $30K; Meela is listed with Göteborg).
Is there a tight time window with multiple rounds clustered near mid-2024?
Mid-2024 shows repeated activity: Tandem Health closed on 2024-06-19 for $10M and Checkproof closed on 2024-06-04 (undisclosed). The same half-year also includes multiple other rounds around summer 2024, such as MucoLife Therapeutics on 2024-09-06 and Enzymatica on 2024-09-12 later in the year, keeping the 2024 band unusually populated.
Are there low-amount outliers that may signal pre-revenue or very small financing sizes relative to the rest?
The smallest disclosed amount is MucoLife Therapeutics’ $30K on 2024-09-06 (Pre-Seed). Multiple other disclosed deals remain far above that floor (e.g., XNK Therapeutics $160K on 2023-10-10 and Monivent $380K on 2024-10-09), making $30K a clear low-end outlier among disclosed figures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.